News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

India Sun Pharmaceutical Industries Ltd Unit Gets U.S. Nod for Cancer Drug


5/4/2011 6:43:15 AM

May 4 (Reuters) - India's Sun Pharmaceutical Industries Ltd on Wednesday said its unit had received approval from the U.S. Food and Drug Administration for its cancer treatment Docefrez injection, sending the unit's shares up 3 percent.

The drug, chemically known as docetaxel, is used to treat breast cancer, lung cancer and prostate cancer, Sun said in a statement.

"This product could potentially give the company over $50 million over a year," said Bino Pathiparampil, vice president at IIFL Capital. "We had been expecting the approval in January-February. This is good news for the stock," he said, referring to shares in Sun's unit, Sun Pharma Advanced Research Co Ltd .


Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES